Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Mydecine Innovations Group Inc (NEO: MYCO)

 
MYCO Technical Analysis
5
As on 6th Dec 2023 MYCO STOCK Price closed @ 0.12 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.61 & Strong Sell for SHORT-TERM with Stoploss of 0.76 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MYCOSTOCK Price

Open 0.12 Change Price %
High 0.12 1 Day 0.00 0.00
Low 0.12 1 Week 0.00 0.00
Close 0.12 1 Month -0.02 -14.29
Volume N/A 1 Year -0.73 -85.88
52 Week High 1.03 | 52 Week Low 0.11
 
NEO Canada Most Active Stocks
CCHW 0.51 6.25%
CCHW 0.51 6.25%
GRAM-U 0.32 6.67%
MEDV 0.03 50.00%
MEDI 0.01 -50.00%
MMED 14.90 9.48%
CYBN 14.15 -9.12%
ABXX 12.20 6.36%
FH 0.04 0.00%
MLC 1.90 0.00%
 
NEO Canada Top Gainers Stocks
MEDV 0.03 50.00%
MMED 14.90 9.48%
GRAM-U 0.32 6.67%
ABXX 12.20 6.36%
CCHW 0.51 6.25%
CCHW 0.51 6.25%
GLDE 17.14 1.72%
FCS-UN 3.20 1.59%
CERE-U 9.95 0.30%
SLVE 14.89 0.27%
 
NEO Canada Top Losers Stocks
MEDI 0.01 -50.00%
MEDI 0.01 -50.00%
CYBN 14.15 -9.12%
CYBN 14.15 -9.12%
FGX 2.94 -3.61%
FGX 2.94 -3.61%
NBND 18.23 -0.33%
REM 15.61 -0.19%
REM 15.61 -0.19%
REM 15.61 -0.19%
 
 
MYCO
Daily Charts		 MYCO
Intraday Charts		 Whats New @
Bazaartrend		 MYCO
Free Analysis
 
MYCO Important Levels Intraday
RESISTANCE0.12
RESISTANCE0.12
RESISTANCE0.12
RESISTANCE0.12
RESISTANCE0.12
RESISTANCE0.12
RESISTANCE0.12
RESISTANCE0.12
 
MYCO Forecast November 2024
Share
4th UP Forecast0.72
3rd UP Forecast0.53
2nd UP Forecast0.41
1st UP Forecast0.29
1st DOWN Forecast-0.05
2nd DOWN Forecast-0.17
3rd DOWN Forecast-0.29
4th DOWN Forecast-0.48
 
MYCO Weekly Forecast
4th UP Forecast0.62
3rd UP Forecast0.46
2nd UP Forecast0.36
1st UP Forecast0.26
1st DOWN Forecast-0.02
2nd DOWN Forecast-0.12
3rd DOWN Forecast-0.22
4th DOWN Forecast-0.38
 
MYCO Forecast2024
4th UP Forecast1.89
3rd UP Forecast1.32
2nd UP Forecast0.97
1st UP Forecast0.62
1st DOWN Forecast-0.38
2nd DOWN Forecast-0.73
3rd DOWN Forecast-1.08
4th DOWN Forecast-1.65
 
 
MYCO Other Details
Segment EQ
Market Capital 75186088.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
MYCO Address
MYCO
 
MYCO Latest News
 
Your Comments and Response on Mydecine Innovations Group Inc
 
MYCO Business Profile
Mydecine Innovations Group Inc., a biotech and life sciences company, engages in the development and commercialization of drugs for treating mental health problems. It develops therapies for veterans, emergency medical service providers, post-traumatic stress disorder, and frontline workers, as well as provides digital health platform and therapeutics; and mental health solutions. The company also engages in the drug discovery and builds nature-sourced psychedelic-assisted therapeutics, compounds, therapy protocols, and unique delivery systems. In addition, it operates farm properties in North America. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for drug development and clinical trial programs. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada. Address: 789 West Pender Street, Vancouver, BC, Canada, V6C 1H2
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service